Anna Ewa Winnicki, PA | |
6800 State Highway 121, Mckinney, TX 75070-2905 | |
(469) 800-5681 | |
(469) 800-5685 |
Full Name | Anna Ewa Winnicki |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 6800 State Highway 121, Mckinney, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407426901 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | PATEMP (Texas) | Secondary |
363A00000X | Physician Assistant | PA14684 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anna Ewa Winnicki, PA 6800 State Highway 121, Mckinney, TX 75070-2905 Ph: (469) 800-5681 | Anna Ewa Winnicki, PA 6800 State Highway 121, Mckinney, TX 75070-2905 Ph: (469) 800-5681 |
News Archive
Researchers have devised a new test to help doctors diagnose ovarian tumours and choose the most appropriate treatment.
The University of Alabama at Birmingham has been awarded nearly $18.9 million by the National Institutes of Health Countermeasures Against Chemical Threats Program and National Institute of Environmental Health Sciences to support the UAB Research Center of Excellence in Arsenicals.
CorVel Corporation (the "Company") announced that the Company's Board of Directors has approved a 1,000,000 share expansion to its existing stock repurchase program, increasing the total number of shares approved for repurchase over the life of the program to 14,150,000 shares.
Geisinger Medical Center will participate in ProTECT III, a groundbreaking National Institute of Health -sponsored research study for the emergency treatment of traumatic brain injuries using the hormone progesterone.
La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.
› Verified 2 days ago